In a proactive move to safeguard public health, Singapore has introduced precautionary screening measures at its major airports, Changi and Seletar, in response to the detection of a potentially more serious variant of Mpox in Sweden and Thailand. The move reflects Singapore’s commitment to maintaining robust defenses against emerging infectious diseases, particularly as international travel continues to recover post-pandemic.
Mpox, formerly known as monkeypox, has been a growing concern for global health authorities. The World Health Organization (WHO) declared it a global public health emergency on August 14 for the second time in two years, prompted by the alarming spread of the disease, especially in the Democratic Republic of Congo (DRC), where over 27,000 cases and 1,300 deaths have been reported since January 2023. The identification of a potentially more virulent variant of Mpox in Sweden and Thailand has further escalated concerns due to its increased transmissibility and severity of symptoms.
In light of these developments, Singapore’s Ministry of Health (MOH), in collaboration with the Ministry of Transport and the Immigration and Checkpoints Authority, has introduced temperature and visual screening for all passengers arriving at Changi and Seletar airports. This initiative aims to detect and manage any potential cases of Mpox before they can lead to community transmission.
The screening process involves non-invasive thermal scanners for temperature checks and trained health officials conducting visual inspections for any signs of rash or other symptoms associated with Mpox. Passengers arriving from countries with known Mpox outbreaks are subject to particular scrutiny. These precautionary measures have also been extended to the country’s sea checkpoints, where crew members and passengers arriving by sea from affected regions will undergo similar screening procedures.
To further mitigate the risk, Singapore’s MOH has confirmed that no direct flights currently operate between Singapore and any nation experiencing an active Mpox outbreak. However, recognizing the possibility of travelers transiting through third countries, the authorities are diligently screening all inbound passengers. In addition to screenings, health advisories prominently displayed at all entry points provide travelers with crucial information on Mpox, including symptoms to watch for and steps to take if they suspect infection.
Travelers entering Singapore are urged to be aware of the enhanced screening measures and cooperate fully with the authorities. If a passenger exhibits fever, rash, or other symptoms indicative of Mpox, they will be referred for immediate medical evaluation to isolate and treat any potential cases and prevent further spread. Travelers are also advised to monitor their health closely during their stay in Singapore and seek medical attention promptly if they develop any symptoms consistent with Mpox. Vigilance is essential, considering the virus’s incubation period, which can range from 5 to 21 days.
Singapore’s response to the Mpox threat is part of its broader public health strategy, which emphasizes preparedness, rapid response, and international collaboration. While no cases of the Mpox Clade I variant have been detected in Singapore to date, the country remains on high alert. Singapore’s public health infrastructure is among the most advanced globally, with state-of-the-art laboratories capable of quickly diagnosing Mpox and other infectious diseases. The country’s healthcare system is also well-equipped to manage and treat any cases that might arise, ensuring that any potential outbreak is swiftly contained.
The emergence of new variants of Mpox underscores the importance of global cooperation in managing infectious diseases. The sharing of information, resources, and best practices is crucial to preventing a widespread outbreak. Singapore’s decision to implement screening measures at its borders is likely to be mirrored by other nations as they seek to protect their populations from this potentially serious variant. The WHO continues to play a central role in coordinating the global response, providing guidance on detection, treatment, and prevention.
Singapore will continue to adapt its strategies to meet new challenges as the situation with Mpox evolves. The introduction of screening measures at airports and sea checkpoints is just one aspect of the country’s comprehensive approach to public health. Singapore’s authorities are prepared to take further action if necessary, including the possibility of quarantine measures or travel restrictions should the threat level increase. For now, the emphasis remains on vigilance, early detection, and the prompt treatment of any cases. By taking these steps, Singapore aims to protect its population and prevent the kind of large-scale outbreak seen in other parts of the world.
Singapore’s implementation of Mpox screening at Changi and Seletar airports, alongside enhanced measures at sea checkpoints, reflects its proactive stance in safeguarding public health. As the world watches the spread of a potentially more serious variant of Mpox, Singapore’s response underscores the importance of preparedness, international cooperation, and the swift implementation of precautionary measures. With these actions, Singapore continues to demonstrate its commitment to maintaining robust defenses against emerging global health threats.
